436 related articles for article (PubMed ID: 29632285)
1. [Cerebellar Ataxia and Autoantibodies].
Nanri K; Yoshikura N; Kimura A; Nakayama S; Otomo T; Shimohata T; Terashi H; Sato T; Yamada J
Brain Nerve; 2018 Apr; 70(4):371-382. PubMed ID: 29632285
[TBL] [Abstract][Full Text] [Related]
2. [Ataxic form of Hashimoto's encephalopathy].
Yoneda M
Rinsho Shinkeigaku; 2012; 52(11):1369-71. PubMed ID: 23196621
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
[TBL] [Abstract][Full Text] [Related]
4. [A case of human immunodeficiency virus infection with cerebellar ataxia that suggested by an association with autoimmunity].
Nagao S; Kondo T; Nakamura T; Nakagawa T; Matsumoto S
Rinsho Shinkeigaku; 2016 Apr; 56(4):255-9. PubMed ID: 27010096
[TBL] [Abstract][Full Text] [Related]
5. Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.
Mitoma H; Adhikari K; Aeschlimann D; Chattopadhyay P; Hadjivassiliou M; Hampe CS; Honnorat J; Joubert B; Kakei S; Lee J; Manto M; Matsunaga A; Mizusawa H; Nanri K; Shanmugarajah P; Yoneda M; Yuki N
Cerebellum; 2016 Apr; 15(2):213-32. PubMed ID: 25823827
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.
Nanri K; Okita M; Takeguchi M; Taguchi T; Ishiko T; Saito H; Otsuka T; Mitoma H; Koizumi K
Intern Med; 2009; 48(10):783-90. PubMed ID: 19443972
[TBL] [Abstract][Full Text] [Related]
7. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
8. [Progressive cerebellar ataxia with euthyroid Hashimoto's disease--implication of autoantibodies associated with Hashimoto's disease in progressive cerebellar ataxia].
Yabe I; Sato K; Soma H; Sasaki H
Rinsho Shinkeigaku; 2008 Sep; 48(9):640-5. PubMed ID: 19048946
[TBL] [Abstract][Full Text] [Related]
9. Hashimoto's encephalopathy as a treatable adult-onset cerebellar ataxia mimicking spinocerebellar degeneration.
Matsunaga A; Ikawa M; Fujii A; Nakamoto Y; Kuriyama M; Yoneda M
Eur Neurol; 2013; 69(1):14-20. PubMed ID: 23128836
[TBL] [Abstract][Full Text] [Related]
10. Spinocerebellar Ataxia Type 31 Exacerbated by Anti-amino Terminal of Alpha-enolase Autoantibodies.
Zeniya S; Sanjo N; Kuwahara H; Ishikawa K; Higashi M; Matsunaga A; Yoneda M; Mizusawa H; Yokota T
Intern Med; 2022; 61(18):2793-2796. PubMed ID: 36104177
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of an anti-mouse cerebellar tissue-derived antigen antibody test in predicting immunotherapy efficacy in patients with idiopathic cerebellar ataxia].
Ohtomo T; Ogino S; Yanai S; Nakayama S; Yajima R; Sugawara M; Yamada J; Aizawa H; Taguchi T; Nanri K
Rinsho Shinkeigaku; 2022 Feb; 62(2):112-122. PubMed ID: 35095045
[TBL] [Abstract][Full Text] [Related]
12. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
[TBL] [Abstract][Full Text] [Related]
13. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
14. [A case of anti-gliadin-antibody-positive cerebellar ataxia effectively treated with intravenous immunoglobulin in which voxel-based morphometry and FineSRT were diagnostically useful].
Nanri K; Otsuka T; Takeguchi M; Taguchi T; Ishiko T; Mitoma H; Koizumi K
Rinsho Shinkeigaku; 2009 Jan; 49(1):37-42. PubMed ID: 19227895
[TBL] [Abstract][Full Text] [Related]
15. [Immune-Mediated Cerebellar Ataxias].
Mitoma H
Brain Nerve; 2021 May; 73(5):611-619. PubMed ID: 34006695
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges.
Mitoma H; Manto M; Hampe CS
Curr Neuropharmacol; 2019; 17(1):33-58. PubMed ID: 30221603
[TBL] [Abstract][Full Text] [Related]
18. [Hashimoto's encephalopathy presenting with isolated cerebellar ataxia in 13 children].
Liao YT; Chen WX; Hou C; Zhu HX; Chen LF; Zeng YR; Wu WX; Liang HC; Li XJ
Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):46-50. PubMed ID: 34986623
[No Abstract] [Full Text] [Related]
19. Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
Yoshikura N; Kimura A; Fukata M; Fukata Y; Yokoi N; Harada N; Hayashi Y; Inuzuka T; Shimohata T
J Neuroimmunol; 2018 Jun; 319():63-67. PubMed ID: 29685291
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for treatment of immune-mediated cerebellar ataxias.
Mitoma H; Hadjivassiliou M; Honnorat J
Cerebellum Ataxias; 2015; 2():14. PubMed ID: 26561527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
